BlueScope (ASX:BSL) share price slides on results

The BlueScope (ASX: BSL) share price is down almost 3% following the company's release of first-half results. Here are the highlights.

| More on:
finger selecting sad face from choice of happy, sad and neutral faces on screen, indicating a falling share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The BlueScope Steel Limited (ASX: BSL) share price is edging lower this morning following the release of its first-half results for FY21. At the time of writing, the steel producer's shares have backtracked 2.78% to $16.80.

Let's take a look and see how the company performed for the period.

What are the highlights?

The BlueScope share price is coming under pressure today despite reporting a positive set of numbers.

In this morning's release, BlueScope advised it achieved a solid performance across its key business metrics.

For the six months ending 31 December, BlueScope delivered total sales revenue of $5,817.4 million, down 1% on the first half of FY20. The slight fall was attributed to lower selling prices caused by unfavourable currency exchange movements in the Australian dollar despite improved demand.

Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) came to $772.5 million, up 75% on the prior corresponding period. Stronger steel spreads such as reduced raw material costs and a lift in volumes from demand supported its operating profitability. The company's largest steelmaking business in Australia and the United States particularly saw strong recovery rates.

Underlying net profit after tax (NPAT) grew to $332.8 million, increasing 67% over this time last year.

After capital expenditure, total group cash flow stood at $265.1 million, a jump of $305 million from H1 FY20.

BlueScope closed the first half with a net cash position of $305.1 million. Previously, the group recorded net cash of $79 million at the end of June last year.

The board declared an unfranked interim dividend of 6 cents per share to be paid to shareholders on 30 March 2021. This is the same amount as management handed out to shareholders in the H1 FY20 period.

Outlook

Looking ahead, BlueScope noted that order and dispatch rates in its key markets remain healthy. Spot steel spreads in North America are forecast to be materially higher than H1 FY21 and longer-term averages. However, due to COVID-19 uncertainty, the business cautioned that the favourable trading conditions might not be sustained.

As a result, BlueScope predicts that underlying EBIT will be in the range of $750 million and $830 million. This will be dependent upon future spread, foreign exchange and market conditions.

About the BlueScope share price

Over the last 12 months, the company's shares have risen to more than 26%, reflecting a recovery in the sector.

During March, BlueScope shares fell to a low of $8.03 before gradually moving along an upwards trend. The company achieved a 52-week high of $18.80 just last month.

Based on the current share price, the company has a market capitalisation of $8.7 billion.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Market News

Why Aeris Resources, Netwealth, Nova Minerals, and Paragon Care shares are dropping today

These shares are under pressure on Friday. Let's find out why.

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Share Market News

Downer EDI wins $870m NZ highway maintenance contracts: What investors need to know

Downer EDI wins major New Zealand state highway maintenance contracts worth NZ$870 million, expanding its infrastructure portfolio.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy for massive returns

The broker sees a lot of value in these big names. Here's what it is recommending.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »